Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1965 1
1968 1
1970 2
1971 3
1972 5
1973 6
1974 9
1975 12
1976 12
1977 13
1978 14
1979 6
1980 26
1981 15
1982 20
1983 26
1984 21
1985 15
1986 21
1987 20
1988 13
1989 11
1990 17
1991 12
1992 8
1993 25
1994 4
1995 14
1996 9
1997 4
1998 6
1999 4
2000 7
2001 1
2002 9
2003 1
2004 5
2005 4
2006 5
2007 11
2008 1
2009 4
2010 4
2011 8
2012 3
2013 6
2014 6
2015 3
2016 3
2017 4
2018 1
2019 1
2020 3
2021 1
2022 5
2023 2
2024 1
2026 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

461 results

Results by year

Filters applied: . Clear all
Page 1
Effectiveness of nifedipine, labetalol, and hydralazine as emergency antihypertension in severe preeclampsia: a randomized control trial.
S D, Novri DA, Hamidy Y, Savira M. S D, et al. F1000Res. 2023 Apr 27;11:1287. doi: 10.12688/f1000research.125944.2. eCollection 2022. F1000Res. 2023. PMID: 37273965 Free PMC article. Clinical Trial.
A single dose administration, four, one, and three patients had 20% MAP reduction in nifedipine, labetalol, and hydralazine group. Three, seven, and one patient had a failure of reaching 20% MAP reduction even after receiving the third dose. The effectiveness of the drugs …
A single dose administration, four, one, and three patients had 20% MAP reduction in nifedipine, labetalol, and hydralazine group. Th …
A clinical trial with valproic acid and hydralazine in combination with gemcitabine and cisplatin followed by doxorubicin and dacarbazine for advanced hepatocellular carcinoma.
Liu YC, Su CW, Ko PS, Lee RC, Liu CJ, Huang YH, Gau JP, Liu JH. Liu YC, et al. Asia Pac J Clin Oncol. 2022 Feb;18(1):19-27. doi: 10.1111/ajco.13443. Epub 2020 Sep 22. Asia Pac J Clin Oncol. 2022. PMID: 32964588 Clinical Trial.
Chemotherapy modulated with valproic acid (VA) as a deacetylation inhibitor of histone and DNA damage response proteins, and hydralazine (HZ) as a DNA hypomethylating agent, hypothetically suppressing DNA repair, were used in phase II trial here for advanced HCC. ...
Chemotherapy modulated with valproic acid (VA) as a deacetylation inhibitor of histone and DNA damage response proteins, and hydralazine …
Plasma norepinephrine and mortality.
Cohn JN. Cohn JN. Clin Cardiol. 1995 Mar;18(3 Suppl I):I9-12. doi: 10.1002/clc.4960181304. Clin Cardiol. 1995. PMID: 7743697 Free article. Review.
Data from the V-HeFT II show that at 2-year follow-up, a progressive rise of plasma norepinephrine was observed in both treatment arms, suggesting that disease progresses despite treatment with either an angiotensin-converting enzyme inhibitor, enalapril, or vasodilator therapy w …
Data from the V-HeFT II show that at 2-year follow-up, a progressive rise of plasma norepinephrine was observed in both treatment arms, sugg …
Treatment of hypertensive emergencies of pregnancy.
Nissen JC. Nissen JC. Clin Pharm. 1982 Jul-Aug;1(4):334-43. Clin Pharm. 1982. PMID: 6764393 Review.
Although many institutions consider hydralazine the antihypertensive agent of choice in pre-eclampsia/eclampsia, there have been no comparative studies to document that hydralazine is the safest or most efficacious agent and only one human study evaluated its effect …
Although many institutions consider hydralazine the antihypertensive agent of choice in pre-eclampsia/eclampsia, there have been no c …
The treatment of heart failure. A methodological review of the literature.
Guyatt GH. Guyatt GH. Drugs. 1986 Dec;32(6):538-68. doi: 10.2165/00003495-198632060-00004. Drugs. 1986. PMID: 3024949 Review.
Four randomised control trials of oral nitrates have shown a reduction in left ventricular filling pressure, and trends favouring active treatment for the indices of exercise capacity and functional status. Of 2 randomised control trials of hydralazine one is totally negat …
Four randomised control trials of oral nitrates have shown a reduction in left ventricular filling pressure, and trends favouring active tre …
Ketanserin and hydralazine in hypertension in pregnancy--a randomised double-blind trial.
Rossouw HJ, Howarth G, Odendaal HJ. Rossouw HJ, et al. S Afr Med J. 1995 Jun;85(6):525-8. S Afr Med J. 1995. PMID: 7652635 Clinical Trial.
OBJECTIVES: To compare ketanserin with hydralazine in the treatment of hypertension in late pregnancy. STUDY DESIGN: Randomised control trial. ...As ketanserin could become an alternative to hydralazine, more studies with larger numbers of patients are needed to com …
OBJECTIVES: To compare ketanserin with hydralazine in the treatment of hypertension in late pregnancy. STUDY DESIGN: Randomised contr …
Hydralazine once daily in hypertension.
Silas JH, Ramsay LE, Freestone S. Silas JH, et al. Br Med J (Clin Res Ed). 1982 May 29;284(6329):1602-4. doi: 10.1136/bmj.284.6329.1602. Br Med J (Clin Res Ed). 1982. PMID: 6805621 Free PMC article. Clinical Trial.
The effects of hydralazine formulation and dose interval were assessed in 20 patients with hypertension well controlled on conventional hydralazine tablets, 100 mg twice daily, in addition to atenolol and a diuretic. The double-blind study used four regimens crossed …
The effects of hydralazine formulation and dose interval were assessed in 20 patients with hypertension well controlled on convention …
Therapeutic trials of pindolol in hypertension: comparison and combination with other drugs.
Fanchamps A. Fanchamps A. Am Heart J. 1982 Aug;104(2 Pt 2):388-406. doi: 10.1016/0002-8703(82)90129-6. Am Heart J. 1982. PMID: 6125096 Review.
In resistant cases, the combination of pindolol with diuretics, methyldopa, or hydralazine was found to significantly increase the responder rate....
In resistant cases, the combination of pindolol with diuretics, methyldopa, or hydralazine was found to significantly increase the re …
461 results